Regulation of insulin-like growth factor binding protein-1 during protracted critical illness.
暂无分享,去创建一个
G. Van den Berghe | R. Baxter | P. Delhanty | D. Mesotten | F. Vanderhoydonc | F. Weekers | K. V. Hardman | Robert C. Baxter
[1] M. Pfaffl,et al. Validities of mRNA quantification using recombinant RNA and recombinant DNA external calibration curves in real-time RT-PCR , 2001, Biotechnology Letters.
[2] G. Van den Berghe,et al. The combined administration of GH‐releasing peptide‐2 (GHRP‐2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP‐2 alone , 2002, Clinical endocrinology.
[3] B. Bistrian,et al. Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.
[4] B. Decallonne,et al. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. , 2001, Methods.
[5] E. Nylén,et al. Humoral markers of severity and prognosis of critical illness. , 2001, Best practice & research. Clinical endocrinology & metabolism.
[6] B A Mizock,et al. Alterations in fuel metabolism in critical illness: hyperglycaemia. , 2001, Best practice & research. Clinical endocrinology & metabolism.
[7] A. Beishuizen,et al. The hypothalamic-pituitary-adrenal response to critical illness. , 2001, Best practice & research. Clinical endocrinology & metabolism.
[8] G. Van den Berghe,et al. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. , 2001, The Journal of clinical endocrinology and metabolism.
[9] L. Giudice,et al. Regulation of insulin-like growth factor-binding protein 1 by hypoxia and 3',5'-cyclic adenosine monophosphate is additive in HepG2 cells. , 2000, The Journal of clinical endocrinology and metabolism.
[10] G. Van den Berghe,et al. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. , 2000, The Journal of clinical endocrinology and metabolism.
[11] G. Van den Berghe,et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. , 1999, The Journal of clinical endocrinology and metabolism.
[12] R. Baxter,et al. Thrity-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients , 1998 .
[13] L. Giudice,et al. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[14] G. Van den Berghe,et al. Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. , 1998, The Journal of clinical endocrinology and metabolism.
[15] R. Baxter,et al. Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[16] L. Giudice,et al. Insulin-like Growth Factor Binding Protein-1: Recent Findings and New Directions , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[17] H. Orskov,et al. The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults. , 1997, The Journal of clinical endocrinology and metabolism.
[18] D. Prough,et al. Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin. , 1997, The American journal of physiology.
[19] R. Hanson,et al. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. , 1997, Annual review of biochemistry.
[20] H. Yki-Järvinen,et al. Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. , 1995, The Journal of clinical endocrinology and metabolism.
[21] R. Baxter,et al. Insulin-like growth factor binding proteins as glucoregulators. , 1995, Metabolism: clinical and experimental.
[22] G. Chrousos,et al. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.
[23] J. Holly,et al. Growth hormone, insulinlike growth factor‐1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease , 1995, Hepatology.
[24] P. Rothwell,et al. Prediction of outcome in intensive care patients using endocrine parameters. , 1995, Critical care medicine.
[25] B A Mizock,et al. Alterations in carbohydrate metabolism during stress: a review of the literature. , 1995, The American journal of medicine.
[26] J. Wahren,et al. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. , 1994, The Journal of clinical endocrinology and metabolism.
[27] J. Holly,et al. Expression of IGFBP-1 in normal and cirrhotic human livers. , 1994, The Journal of endocrinology.
[28] D. Powell,et al. Identification of an insulin-responsive element in the promoter of the human gene for insulin-like growth factor binding protein-1. , 1993, The Journal of biological chemistry.
[29] D. Powell,et al. Identification of a promoter element which participates in cAMP-stimulated expression of human insulin-like growth factor-binding protein-1. , 1993, The Journal of biological chemistry.
[30] C. Conover,et al. Cortisol increases plasma insulin-like growth factor binding protein-1 in humans. , 1993, Acta endocrinologica.
[31] L. Carlsson,et al. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. , 1992, The Journal of clinical endocrinology and metabolism.
[32] J. Holly,et al. Levels of GH binding activity, IGFBP‐1, insulin, blood glucose and cortisol in intensive care patients , 1991, Clinical endocrinology.
[33] D. Clemmons,et al. Insulin-dependent regulation of insulin-like growth factor-binding protein-1. , 1990, The Journal of clinical endocrinology and metabolism.
[34] R. Baxter,et al. Regulation of growth hormone-independent insulin-like growth factor-binding protein (BP-28) in cultured human fetal liver explants. , 1989, The Journal of clinical endocrinology and metabolism.
[35] J. Chirgwin,et al. Isolation of RNA. , 1989, Methods in enzymology.
[36] T. Chard,et al. ORCADIAN VARIATION OF GH‐INDEPENDENT IGF‐BINDING PROTEIN IN DIABETES MELLITUS AND ITS RELATIONSHIP TO INSULIN. A NEW ROLE FOR INSULIN? , 1988, Clinical endocrinology.
[37] R. Baxter,et al. Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma. , 1988, Acta endocrinologica.
[38] C. Cowell,et al. Regulation of the growth hormone-independent growth factor-binding protein in children. , 1988, The Journal of clinical endocrinology and metabolism.
[39] M. Seppälä,et al. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. , 1988, The Journal of clinical endocrinology and metabolism.
[40] C. Cowell,et al. Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. , 1987, The Journal of clinical endocrinology and metabolism.
[41] R. Baxter,et al. Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity. , 1987, The Journal of clinical endocrinology and metabolism.
[42] H. Bingham,et al. Physiological and metabolic correlations in human sepsis , 1980 .
[43] J H Siegel,et al. Physiological and metabolic correlations in human sepsis. Invited commentary. , 1979, Surgery.